Back to Top

Benchling for Cell Therapy R&D


Oct 20, 2021


Cell therapies such as stem cells, CAR T cells, and TCR have been of significant interest in research over the past few decades. The FDA approval of CAR T therapies has led to renewed interest in the field. As companies rush to bring more novel cell therapies to the market, they face several R&D complexities. This application note discusses how Benchling’s capabilities can solve these complexities and improve speed to milestone for organizations developing cell therapies.

Application File

Benchling for Cell Therapy R&D.pdf